Gustave Roussy, Cancer Campus, Grand Paris

This study is testing an investigational pill called valemetostat for adults with advanced solid tumors that have stopped responding to standard treatments. It is specifically for people whose cancers have certain genetic changes affecting a cellular system called SWI/SNF. The go…

This study aims to find out if the 9-valent HPV vaccine can prevent high-grade, precancerous lesions from coming back after they have been treated. It will involve about 984 patients aged 18-55 who have recently been treated for these HPV-related lesions. Participants will be ran…

This study is testing whether a smartphone app that scans food labels can help people at high genetic risk for cancers like breast, colon, or pancreatic cancer eat fewer ultra-processed foods. Over 12 weeks, researchers will compare diet improvements between people who just get s…

This study aims to see if a cannabidiol (CBD) oral solution can safely reduce joint pain and stiffness caused by standard hormone therapy in people with early-stage breast cancer. It will involve 130 participants who are experiencing significant pain from their medication. The tr…

This study aims to understand the long-term side effects of different treatment sequences for advanced neuroendocrine tumors, a rare type of cancer. Researchers will follow 1100 patients in France for up to 5 years, tracking their treatments and any persistent side effects that l…